Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Center for Medical Weight Loss (CMWL) vs Wisp

vs+2.5
Wisp
Graded #243

Lower grade

The verdict

Center for Medical Weight Loss (CMWL) takes it — 66.9/100 to 64.4/100.

Center for Medical Weight Loss (CMWL) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Center for Medical Weight Loss (CMWL) runs a 100 percent online, physician-supervised GLP-1 program using compounded semaglutide and tirzepatide with flat any-dose pricing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCenter for Medical Weight Loss (CMWL) +26
76
50
Dose & formulationWisp +4
72
76
Clinical oversightWisp +4
78
82
Labs & monitoringWisp +1
52
53
FulfillmentCenter for Medical Weight Loss (CMWL) +5
71
66
Contract termsWisp +35
20
55
Center for Medical Weight Loss (CMWL) · left barWisp · right bar

The numbers

MetricCenter for Medical Weight Loss (CMWL)Wisp
WeighScore66.9/10064.4/100
GradeCC
Scorecard rank#171#243
Semaglutide$149/mo (all doses, compounded)$225/mo (compounded oral)
Tirzepatide$239/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes

Strengths

  • Very competitive flat any-dose pricing (semaglutide from 116 dollars per month, tirzepatide from 159 dollars per month)
  • Established Center for Medical Weight Loss brand with physician supervision and clinical support
  • Fast 24-hour approvals and free three to five day shipping

Where it loses points

  • Some states are ineligible and the eligible-state list is not published
  • Compounding pharmacy is not named publicly
  • Lowest per-month prices require a three-month prepaid commitment
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard